Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Telix Pharmaceuticals (innovations) Pty Ltd

Clinical trials sponsored by Telix Pharmaceuticals (innovations) Pty Ltd, explained in plain language.

Now part of Telix Pharmaceuticals Limited TLX ASX

Subsidiary of Telix, a radiopharmaceutical company developing targeted radiation therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Terminated 1

Can a radioactive antibody light up hidden tumors?

Diagnosis Recruiting now

This trial is testing an experimental imaging agent called 89Zr-olaratumab in people with soft tissue sarcoma or other solid tumors that express a protein called PDGFRα. The agent is a radioactive-labeled antibody designed to bind to PDGFRα and show up on PET scans, potentially r…

Phase: PHASE1 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Ltd • Aim: Diagnosis

Last updated Aug 16, 2026 00:00 UTC